Adding Talazoparib to Enzalutamide Prolongs Imaging-Based PFS in Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer with Alterations in HRR Genes By Ogkologos - June 15, 2026 11 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TALAPRO-3 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Therapy Rottweiler, known as Dogtor Loki, Is Delivering ‘Hero Healing Kits’... April 16, 2020 Blind Customer Surprised With Sweet Message In Braille For Her Birthday August 28, 2021 FDA Approves Belzutifan for Advanced Renal Cell Carcinoma January 19, 2024 NHS ‘understaffed and underequipped’ to tackle cancer, say 3 in 4... May 25, 2022 Load more HOT NEWS FDA Approves Osimertinib as Adjuvant Therapy for NSCLC with EGFR Exon... Largest Study on Frequent Aspirin Use Supports Reduction in Ovarian Cancer... Pembrolizumab Improves Survival in Patients from Asia with Previously Treated Advanced... First treatment approved in England for advanced bile duct cancer
